Challenges of Gene Editing Therapies for Genodermatoses

Area of Science:

• Genetics
• Dermatology
• Molecular Biology

Background:

• Genodermatoses are inherited skin diseases, often monogenic, with limited curative options.
• These conditions can cause severe health issues, including early-onset cancers and life-threatening skin damage.
• There is a significant clinical need for single-intervention curative treatments.

Purpose of the Study:

• To review the potential of gene editing technologies for treating genodermatoses.
• To discuss essential factors for translating gene editing into clinical applications.
• To guide researchers in developing gene editing approaches for inherited skin disorders.

Main Methods:

• Exploration of gene editing tools: CRISPR-Cas9, homology-directed repair, base editing, and prime editing.
• Focus on correcting pathogenic mutations responsible for genodermatoses.
• Discussion of strategies to optimize editing efficiency and minimize off-target effects.

Main Results:

• Gene editing tools show promise for correcting disease-causing mutations in genodermatoses.
• Optimizing editing efficiency and specificity is crucial for therapeutic success.
• Effective delivery systems are essential for clinical translation.

Conclusions:

• Gene editing represents a promising frontier for treating genodermatoses.
• Addressing challenges in efficiency, specificity, and delivery is vital for clinical application.
• This review provides a framework for future research and development in gene editing for inherited skin diseases.